New York & Company, Inc. 4
4 · New York & Company, Inc. · Filed Feb 21, 2007
Insider Transaction Report
Form 4
Crystal Richard P
DirectorChairman and CEO
Transactions
- Exercise/Conversion
Options to Purchase Common Stock
2007-02-20$0.11/sh−50,000$5,500→ 1,181,367 totalExercise: $0.11Exp: 2012-11-27→ Common Stock (50,000 underlying) - Sale
Common Stock
2007-02-20$15.85/sh−50,000$792,450→ 358,553 total - Exercise/Conversion
Common Stock
2007-02-20$0.11/sh+50,000$5,500→ 408,553 total
Holdings
- 486,453
Options to Purchase Common Stock
Exercise: $3.23Exp: 2014-05-14→ Common Stock (486,453 underlying) - 45,000
Options to Purchase Common Stock
Exercise: $15.76Exp: 2016-03-15→ Common Stock (45,000 underlying)
Footnotes (4)
- [F1]This exercise of options to purchase Common Stock and the sale of Common Stock are pursuant to the reporting person's 10b5-1 Plan which commenced on November 20, 2006 under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]Includes 343,553 shares of Common Stock. Also includes 15,000 shares of restricted stock which will be earned pursuant to a schedule ending on August 16, 2010 depending on company performance and continued employment through August 16, 2010, at which time such shares shall vest. If certain company performance objectives are met throughout the 4-year period, the restricted stock will be earned as follows: 1,875 on February 3, 2007; 3,750 on February 2, 2008; 3,750 on January 31, 2009; 3,750 on January 30, 2010; and 1,875 on August 16, 2010. If on August 16, 2010, the company's cumulative 4-year performance meets the cumulative 4-year performance objectives, then any unearned shares will vest.
- [F3]The options to purchase Common Stock are currently exercisable.
- [F4]The options become exercisable in five annual installments on the following dates: 6,750 shares on March 15, 2007; 6,750 shares on March 15, 2008; 9,000 shares on March 15, 2009; 11,250 shares on March 15, 2010; and 11,250 shares on March 15, 2011.